LabPulse.com staff writersMergers & AcquisitionsBruker to acquire NanoString for $392.6MNanoString has reached an agreement with Bruker in which Bruker will purchase substantially all of NanoString's assets for approximately $392.6 million in cash, as well as assume certain NanoString liabilities.April 18, 2024Trends and FinanceDermTech receives delisting warning from NasdaqMelanoma diagnostics company DermTech announced that it has received a delisting warning from Nasdaq.April 17, 2024CollaborationNightingale Health to open U.S. lab, collaborate with Englander Institute at Weill CornellPreventive healthcare company Nightingale Health will open a laboratory in the U.S. In addition, the Englander Institute for Precision Medicine at Weill Cornell Medicine has signed on as its first customer.April 17, 2024Trends and FinanceCo-Diagnostics opens manufacturing facility in UtahMolecular diagnostics firm Co-Diagnostics has opened a new manufacturing facility in South Salt Lake, UT, holding a ribbon-cutting event to inaugurate the facility on April 11.April 16, 2024Diagnostic TechnologiesVeracyte to share bundle of genomic classifier studies at AUA 2024Veracyte has announced that the American Urological Association's May meeting will feature nine sessions related to evaluations of its prostate cancer and bladder cancer genomic tests.April 16, 2024Diagnostic TechnologiesBabson adds hand-warming to blood testing mini-draws in Texas pharmaciesAustin, TX-based Babson Diagnostics said it has received positive feedback for its hand-warmer, which is used as part of a finger-stick blood sample collection device in retail pharmacies.April 16, 2024Trends and FinanceOraSure discloses cybersecurity breachOraSure Technology disclosed a cybersecurity incident involving data theft that occurred in late March.April 15, 2024Policy and RegulationEuropean Commission approves Illumina's plan to divest GrailThe European Commission has approved Illumina's plan to divest multicancer early detection test maker Grail under the European Union Merger Regulation adopted by the EC in October 2023.April 12, 2024Regulatory ApprovalRoche, Lilly Alzheimer's blood test granted FDA breakthrough device designationThe Alzheimer's blood test developed through a collaboration between Roche and Lilly has been granted a breakthrough device designation by the U.S. Food and Drug Administration (FDA).April 11, 2024Regulatory ApprovalRoche's breast cancer CDx receives CE MarkRoche has received the CE Mark for the first companion diagnostic (CDx) test to identify patients with HER2-low metastatic breast cancer who may be eligible for treatment with Enhertu.April 10, 2024Previous PagePage 2 of 340Next PageTop StoriesFDA ClearancePillar Biosciences gets FDA approval for NGS solid tumor profiling testPillar Biosciences has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its OncoReveal CDx pan-cancer next-generation sequencing (NGS) test for general solid tumor profiling.ValidationImmunovia announces positive results for next-gen pancreatic cancer testCollaborationVertex to pay $25M upfront to scale cell manufacturing technologyMergers & AcquisitionsLabcorp buys Invitae portfolio for $239MSponsor ContentVisit our Molecular Diagnostics Community
